Patent details
93312
Product Name:
"Migalastat ou un sel de celui-ci , y compris le sel de chlorhydrate"
Basic Information
- Publication number:
- 93312
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
-
EP141687483
- Legal Status:
- Inactive
- Application number:
- 93312
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/15/1082 - Galafold - migalastat
- Marketing Authorization Type:
-
- Marketing Authorization Date:
- 31/05/2016
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
-
Dates
- Filing date:
- 16/11/2016
- First Marketing Authorization date:
- 31/05/2016
- Grant date:
- 26/01/2017
- Activation date:
- Publication date:
- 26/01/2017
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 31/05/2031
- SPC Extension Expiration:
- 31/05/2031
- Rejection date:
- Withdrawal date:
Owner
- From:
- 16/11/2016
-
-
- Name:
- Amicus Therapeutics Inc.
- Address:
- 1 Cedar Brook Drive, Cranbury, NJ 08512, United States (US)
Agent
1
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 26/01/2017
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
2
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 16/11/2016
- Address:
- PO Box 48, 8001, STRASSEN, Luxembourg (LU)
- To:
- 26/01/2017
Inventor
1
- Name:
- Castelli Jeff
- Address:
- United States (US)
2
- Name:
- Lockhart David
- Address:
- United States (US)
Publication
Bulletin
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2017/02
- Publication date:
- 22/06/2017
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
Annual Fees
- Annual Fee Due Date:
- 31/05/2027
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-